DAX ®13.054,80-0,65%TecDAX ®3.037,12-0,16%Dow Jones27.677,79+0,10%NASDAQ 1008.308,40+0,14%
finanztreff.de

PRESS RELEASE: RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months

| Quelle: Dow Jones Newsw... | Lesedauer etwa 8 min. | Text vorlesen Stop Pause Fortsetzen


DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Quarter Results/Quarter
Results
RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in
Revenues in the Third Quarter and in the First Nine Months

2019-11-08 / 07:04
The issuer is solely responsible for the content of this announcement.

*Corporate News*

Bad Neustadt / Saale | 8th November 2019

*RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in
Revenues in the Third Quarter and in the First Nine Months*

· *Revenues increased in the first nine months of 2019 by 4.6 % to Euro
970.8 million; number of patients treated rose to 647,345*

· *With Medgate Deutschland RHÖN-KLINIKUM AG will in future offer
access irrespective of time or place to medical advice and treatment for
both urgent and/or general medical questions via telephone, video,
internet and smartphone app*

· *Strategic projects for future growth well on schedule; start of second
stage of construction at campus in Bad Neustadt*

· *Earnings before interest, taxes, depreciation and amortisation (EBITDA)
and net consolidated profit as expected to be lower than last year*

· *Guidance for 2019 is confirmed: Revenues in the amount of Euro 1.30
billion +/- 5 %;*
*EBITDA in a range from Euro 117.5 million to Euro 127.5 million*

Following an increase in revenues in the third quarter and also in the first
nine months RHÖN-KLINIKUM AG, one of the leading healthcare providers
in Germany, remains well on track to reach its goals for financial year 2019
despite a market environment which is characterised by increasing regulation
and bureaucracy. Entering the forward-looking telemedicine market, our
RHÖN campus concept for healthcare which overcomes the barriers between
out-patient and in-patient services and the consistent progress of continued
digitalisation in our company for the provision of high-quality healthcare
are important pillars in our corporate strategy.

Stephan Holzinger, CEO of RHÖN-KLINIKUM AG, stated: "We are only
partially satisfied with our results for the first nine months. In
comparison with the first six months of 2019 we are now also facing
operative challenges at most of our sites. We are already approaching the
challenges systematically by urgently implementing specific staffing,
organisational and technical measures which are designed to improve our
operative performance and maintain our leading position in a competitive
market. Our investments and strategic projects, such as starting the second
stage of construction at our campus in Bad Neustadt and the building
projects at the university hospitals in Giessen and Marburg, are well on
schedule. We are pleased to report that there is growth in our acute medical
care."

*Increase in Revenues - Operative Earnings and Net Consolidated Profit as
Expected to be Lower Than Last Year*

Revenues rose by 4.6 % to Euro 970.8 million in the first nine months of
2019. The strong growth in revenues mainly came from our acute medical care.
Earnings before interest, taxes, depreciation and amortisation (EBITDA)
dropped by 4.9 % to Euro 97.5 million following Euro 102.5 million in the
same period of last year. The EBITDA margin stood at 10.0 % after 11.0 % in
the previous year. Net consolidated profit amounted to Euro 37.8 million
after Euro 47.6 million last year.

It should be taken into consideration with respect to the drop in EBITDA
that the third quarter of last year was influenced by a positive one-off
effect on EBITDA in the amount of Euro 20 million from the agreement on
separate accounting at the university hospitals in Giessen and Marburg.
Increased earnings from the university out-patient clinics in Giessen and
Marburg as well as subsequent effects from the Fresenius/Helios transaction
had a positive effect on EBITDA in the first nine months of financial year
2019. The improvement programme which we initiated in 2017 and which has
since been implemented throughout our corporate group also contributed
significantly to the development of our results and also secured the
results.

With 71.6 % the equity ratio continues at a very high level. As part of its
long-term financial strategy RHÖN-KLINIKUM AG exploited the favourable
interest rate environment in July 2019 and issued registered bonds with a
total nominal value of Euro 60.0 million and a term of 20 years. Our company
has now a strong financial foundation with a syndicated credit line, a
promissory note loan as well as the registered bond.

*Strategic Projects - Second Stage of Construction at Campus in Bad
Neustadt*

The first nine months were characterised by start-up effects in providing
forward-looking and improved healthcare at the new campus in Bad Neustadt.
The fusion and cultural integration of four clinics which had been working
independently from each other for decades , the new teams which needed to
establish themselves, the new arrangements in the medical and organisational
processes as well as technical challenges all took up a little more time
than originally expected. Also, the reduction in the number of patients at
the beginning of the year which was associated with the move initially had a
noticeable effect on the development of the operative results.

As part of the redevelopment of our campus site in Bad Neustadt the second
stage of construction has been started with, among other things, the
addition of an in-patient rehab unit for the psychosomatic clinic.
RHÖN-KLINIKUM AG has therefore acknowledged the growing demand for such
services. As of 1st January 2020 we shall add neurosurgery to our range of
services at our site. We have also been able to win renowned senior
physicians for important specialist areas at our other sites.

*Preparations on Schedule for the Start of Medgate Deutschland *

RHÖN-KLINIKUM AG will soon be represented on the growing telemedicine
market with Medgate Deutschland. The Investment, Strategy and Finance
Committee of the Supervisory Board of RHÖN-KLINIKUM AG with the power
of resolution has approved the establishment of a joint company called
Medgate Deutschland GmbH with the telemedicine provider Medgate. A unanimous
resolution by the Board of RHÖN-KLINIKUM AG was also passed prior to
the unanimous resolution by the Supervisory Board. RHÖN-KLINIKUM AG
will hold a majority stake of 51 % of the shares of the new company which
will be registered in Germany. Medgate which is registered in Basel will
hold 49 % of the shares. In future Medgate Deutschland will provide patients
with advice and treatment within the German regulatory framework for both
urgent and/or general medical questions via telephone, video, internet and a
smartphone app in an initial expansion stage. RHÖN-KLINIKUM AG has
already been using telemedical processes for many years in preclinical
trials, in-patient and out-patient care and also in the after-care process.
Medgate Deutschland is a sensible strategic addition to our portfolio.

*Confirmation of Guidance*

Our guidance for 2019 is confirmed. RHÖN-KLINIKUM AG expects revenues
in the amount of Euro 1.30 billion +/- 5 % for the current financial year.
We also expect earnings before interest, taxes, depreciation and
amortisation (EBITDA) in the range of Euro 117.5 million to Euro 127.5
million.

Due to tighter nursing legislation, such as the German regulation for the
threshold for nursing staff (Pflegepersonaluntergrenzen-Verordnung) and the
German nursing staff reinforcement act (Pflegepersonalstärkungsgesetz)
RHÖN-KLINIKUM AG currently assumes that its corporate group will be
burdened with an additional low two-digit million amount in financial year
2020.

Due to our large sites with highly specialised centres we can react better
to changes and growing demands than the overall healthcare market.


*RHÖN-KLINIKUM AG* is one of the largest healthcare providers in
Germany. The hospital group offers excellent medical care with a direct link
to universities and research institutes. More than 850,000 patients are
treated every year at the five group hospitals located in Bad Berka, Bad
Neustadt, Frankfurt (Oder), Giessen and Marburg where more than 17,000
employees work. With the RHÖN campus concept the Company is currently
implementing a new and forward-looking project which raises fully
comprehensive healthcare in rural areas to a new level of excellence and is
geared to the growing needs of patients.

More information under www.rhoen-klinikum-ag.com [1]

Contact Persons:

RHÖN-KLINIKUM AG | Head of Corporate Communications and Marketing
Elke Pfeifer
Telephone: +49 9771 65-1327 | E-Mail: elke.pfeifer@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Head of Investor Relations and Treasury
Julian Schmitt
Telephone: +49 9771 65-1536 | E-Mail: julian.schmitt@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Schlossplatz 1 | 97616 Bad Neustadt / Saale, Germany

2019-11-08 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: RHÖN-KLINIKUM AG
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich;
Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg,
Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 908015

End of News DGAP News Service

908015 2019-11-08



(MORE TO FOLLOW) Dow Jones Newswires

November 08, 2019 01:04 ET ( 06:04 GMT)
Werbung

Das könnte Sie auch interessieren

News-Suche

Suchbegriff:

Aktuelle Videos

zur Mediathek
Werbung

Werbung
Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
Was wünschen Sie sich von der Großen Koalition?
Jetzt abstimmen!
Alle Umfragen ansehen